Go Pro
→ The cat is out the bag (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$61.93
-1.8%		$54.70
$38.91
▼
$147.03
$1.82B0.7488,933 shs398,852 shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$80.49
-1.5%		$92.18
$78.27
▼
$118.01
$1.87B0.5360,010 shs299,005 shs
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$14.75
-2.9%		$15.14
$9.22
▼
$19.60
$521.39M1.94167,193 shs141,498 shs
Omnicell, Inc. stock logo
OMCL
Omnicell
$34.82
+0.3%		$39.46
$29.06
▼
$55.00
$1.58B0.97658,498 shs673,318 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-2.01%+1.79%-3.35%+49.97%-27.66%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
-1.51%+1.03%-23.91%-14.81%-14.88%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-2.90%+4.39%+4.31%-6.29%+57.59%
Omnicell, Inc. stock logo
OMCL
Omnicell
+0.32%+4.22%-6.27%-19.02%+6.09%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$61.93
-1.8%		$54.70
$38.91
▼
$147.03
$1.82B0.7488,933 shs398,852 shs
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$80.49
-1.5%		$92.18
$78.27
▼
$118.01
$1.87B0.5360,010 shs299,005 shs
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$14.75
-2.9%		$15.14
$9.22
▼
$19.60
$521.39M1.94167,193 shs141,498 shs
Omnicell, Inc. stock logo
OMCL
Omnicell
$34.82
+0.3%		$39.46
$29.06
▼
$55.00
$1.58B0.97658,498 shs673,318 shs
Options Trading Made Easy - Download Now Cover
Options Trading Made Easy - Download Now

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-2.01%+1.79%-3.35%+49.97%-27.66%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
-1.51%+1.03%-23.91%-14.81%-14.88%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-2.90%+4.39%+4.31%-6.29%+57.59%
Omnicell, Inc. stock logo
OMCL
Omnicell
+0.32%+4.22%-6.27%-19.02%+6.09%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.21
Hold$66.196.87% Upside
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
2.33
Hold$110.6037.41% Upside
NeuroPace, Inc. stock logo
NPCE
NeuroPace
2.78
Moderate Buy$19.2930.75% Upside
Omnicell, Inc. stock logo
OMCL
Omnicell
2.67
Moderate Buy$57.8666.16% Upside

Current Analyst Ratings Breakdown

Latest NPCE, LMAT, INSP, and OMCL Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/24/2026
Omnicell, Inc. stock logo
OMCL
Omnicell
KeyCorp logo
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
8/19/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (D) ➝ Sell (D+)
8/18/2026
Omnicell, Inc. stock logo
OMCL
Omnicell
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold (C-) ➝ Hold (C)
8/17/2026
NeuroPace, Inc. stock logo
NPCE
NeuroPace
Cantor Fitzgerald logo
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingOverweight
8/17/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
8/14/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy (B-) ➝ Hold (C+)
8/7/2026
Omnicell, Inc. stock logo
OMCL
Omnicell
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeHold ➝ Strong Sell
8/5/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$104.00 ➝ $94.00
8/5/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
Barrington Research logo
Barrington Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
8/4/2026
Omnicell, Inc. stock logo
OMCL
Omnicell
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold (C-)
8/4/2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
KeyCorp logo
KeyCorp
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSector Weight
(Data available from 9/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$911.98M1.96$2.81 per share22.02$28.56 per share2.17
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$249.60M7.38$2.86 per share28.16$18.38 per share4.38
NeuroPace, Inc. stock logo
NPCE
NeuroPace
$99.99M5.06N/AN/A$0.35 per share42.14
Omnicell, Inc. stock logo
OMCL
Omnicell
$1.18B1.34$2.77 per share12.55$28.40 per share1.23
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
$145.42M$4.6213.4040.744.7915.03%8.64%7.45%11/2/2026 (Estimated)
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$57.73M$2.8528.2425.392.3625.02%15.63%10.06%11/5/2026 (Estimated)
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$21.47M-$0.57N/AN/AN/A-19.34%-105.64%-16.51%11/3/2026 (Estimated)
Omnicell, Inc. stock logo
OMCL
Omnicell
$2.05M$0.8441.4533.810.873.13%5.66%3.57%10/29/2026 (Estimated)

Latest NPCE, LMAT, INSP, and OMCL Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2026Q2 2026
NeuroPace, Inc. stock logo
NPCE
NeuroPace
-$0.2179-$0.18+$0.0379-$0.18$22.61 million$22.83 million
8/4/2026Q2 2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$0.8070$0.74-$0.0670$0.74$71.47 million$70.38 million
8/3/2026Q2 2026
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
-$0.2359$0.14+$0.3759$0.01$194.72 million$200.58 million
7/30/2026Q2 2026
Omnicell, Inc. stock logo
OMCL
Omnicell
$0.4675$0.94+$0.4725$0.52$310.21 million$312.21 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/AN/AN/AN/AN/A
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
$1.001.24%+16.05%35.09%14 Years
NeuroPace, Inc. stock logo
NPCE
NeuroPace
N/AN/AN/AN/AN/A
Omnicell, Inc. stock logo
OMCL
Omnicell
N/AN/AN/AN/AN/A

Latest NPCE, LMAT, INSP, and OMCL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/28/2026
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
quarterly$0.251.21%8/20/20268/20/20269/3/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
N/A
8.55
6.16
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
0.40
16.31
13.96
NeuroPace, Inc. stock logo
NPCE
NeuroPace
4.97
4.94
3.91
Omnicell, Inc. stock logo
OMCL
Omnicell
0.13
1.64
1.43

Institutional Ownership

CompanyInstitutional Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
94.91%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
84.64%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
78.83%
Omnicell, Inc. stock logo
OMCL
Omnicell
97.70%

Insider Ownership

CompanyInsider Ownership
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
2.20%
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
7.40%
NeuroPace, Inc. stock logo
NPCE
NeuroPace
19.20%
Omnicell, Inc. stock logo
OMCL
Omnicell
2.92%
CompanyEmployeesShares OutstandingFree FloatOptionable
Inspire Medical Systems, Inc. stock logo
INSP
Inspire Medical Systems
1,33328.91 million28.27 millionOptionable
LeMaitre Vascular, Inc. stock logo
LMAT
LeMaitre Vascular
49022.87 million21.18 millionOptionable
NeuroPace, Inc. stock logo
NPCE
NeuroPace
17034.32 million27.73 millionOptionable
Omnicell, Inc. stock logo
OMCL
Omnicell
3,58045.48 million44.15 millionOptionable

Recent News About These Companies

TraceLink, Omnicell Integrate DSCSA Compliance Into Hospital Pharmacy Workflows
September 3 at 2:05 PM  |  rttnews.comhttps://www.rttnews.com/3688355/tracelink-omnicell-integrate-dscsa-compliance-into-hospital-pharmacy-workflows.aspx
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations
September 3 at 10:31 AM  |  prnewswire.co.ukP
TraceLink and Omnicell Integrate DSCSA Compliance Solution into Hospital Pharmacy Operations
September 3 at 10:00 AM  |  prnewswire.comhttps://www.prnewswire.com/news-releases/tracelink-and-omnicell-integrate-dscsa-compliance-solution-into-hospital-pharmacy-operations-302869042.html
Legal & General Group Plc Buys Shares of 173,267 Omnicell, Inc. $OMCL
September 3 at 4:40 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-legal-general-group-plc-buys-shares-of-173267-omnicell-inc-omcl-2026-09-03/
Corient Private Wealth LP Acquires New Holdings in Omnicell, Inc. $OMCL
September 3 at 3:44 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-corient-private-wealth-lp-acquires-new-holdings-in-omnicell-inc-omcl-2026-09-03/
Moore Capital Management LP Buys Shares of 87,760 Omnicell, Inc. $OMCL
September 1 at 5:44 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-moore-capital-management-lp-buys-shares-of-87760-omnicell-inc-omcl-2026-09-01/
Man Group plc Invests $3.17 Million in Omnicell, Inc. $OMCL
September 1 at 4:56 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-man-group-plc-invests-317-million-in-omnicell-inc-omcl-2026-09-01/
Omnicell to Present at the Wells Fargo 21st Annual Healthcare Conference
August 31, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/omnicell-present-wells-fargo-21st-200100262.html
Omnicell (NASDAQ:OMCL) Trading Up 4.7% - Here's Why
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-omnicell-nasdaq-omcl-trading-up-47-heres-why-2026-08-31/
153,338 Shares in Omnicell, Inc. $OMCL Purchased by Empowered Funds LLC
August 31, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-153338-shares-in-omnicell-inc-omcl-purchased-by-empowered-funds-llc-2026-08-31/
Jefferies Financial Group Inc. Invests $1.52 Million in Omnicell, Inc. $OMCL
August 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-jefferies-financial-group-inc-invests-152-million-in-omnicell-inc-omcl-2026-08-30/
Deutsche Bank AG Purchases New Shares in Omnicell, Inc. $OMCL
August 29, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-deutsche-bank-ag-purchases-new-shares-in-omnicell-inc-omcl-2026-08-29/
157,995 Shares in Omnicell, Inc. $OMCL Purchased by Connor Clark & Lunn Investment Management Ltd.
August 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-157995-shares-in-omnicell-inc-omcl-purchased-by-connor-clark-lunn-investment-management-ltd-2026-08-27/
BlackRock Inc. Buys Shares of 7,539,602 Omnicell, Inc. $OMCL
August 27, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-blackrock-inc-buys-shares-of-7539602-omnicell-inc-omcl-2026-08-27/
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL) and Guardant Health (GH)
August 26, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/GH/pressreleases/4022481/analysts-offer-insights-on-healthcare-companies-omnicell-omcl-and-guardant-health-gh/
Omnicell: Offers Good Value, But Uncertainty Remains
August 25, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4940108-omnicell-offers-good-value-but-uncertainty-remains?utm_source=marketbeat.com&utm_medium=referral&feed_item_type=article?source=MarketBeat
Why Omnicell (OMCL) is a Top Value Stock for the Long-Term
August 24, 2026  |  zacks.comhttps://www.zacks.com/stock/news/2978933/why-omnicell-omcl-is-a-top-value-stock-for-the-long-term?cid=cs-stocknewsapi-ft-fundamental_analysis|zacks_education_value_score-2978933
Martin & Co. Inc. TN Takes $5.26 Million Position in Omnicell, Inc. $OMCL
August 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-martin-co-inc-tn-takes-526-million-position-in-omnicell-inc-omcl-2026-08-23/
B. Metzler seel. Sohn & Co. AG Buys New Position in Omnicell, Inc. $OMCL
August 23, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-b-metzler-seel-sohn-co-ag-buys-new-position-in-omnicell-inc-omcl-2026-08-23/
Trillium Asset Management LLC Buys New Position in Omnicell, Inc. $OMCL
August 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-trillium-asset-management-llc-buys-new-position-in-omnicell-inc-omcl-2026-08-21/
Omnicell, Inc. (NASDAQ:OMCL) Given Consensus Recommendation of "Moderate Buy" by Analysts
August 21, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/omnicell-inc-nasdaqomcl-given-consensus-recommendation-of-moderate-buy-by-analysts-2026-08-21/

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Laboratory with a cryogenic quantum processor chamber, optical laser setup on a table, and data monitors displaying waveforms.
Quantum Earnings Week: Winners and Losers Are Finally Emerging
By Nathan Reiff | August 8, 2026
A quantum computing processor glows inside a gold-plated dilution refrigerator in a research laboratory.
The Quantum Race Is Heating Up—And 2 Small Players Stand Out
By Nathan Reiff | August 17, 2026
NVIDIA logo displayed on a computer chip surrounded by illuminated green circuit board traces.
NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
By Thomas Hughes | August 11, 2026
SoundHound AI logo displayed within a glowing orange ring against a dark background with light wave effects.
SoundHound AI Sends a Loud Signal After Its Q2 Earnings Beat
By Thomas Hughes | August 10, 2026
Medical imaging scanner with exposed internal components being assembled in a manufacturing facility with computer workstations.
Inside Teledyne's Bold Bet on the Future of Medical Imaging
By Jeffrey Neal Johnson | August 14, 2026
Inspire Medical Systems stock logo

Inspire Medical Systems NYSE:INSP

$61.93 -1.14 (-1.81%)
Closing price 09/3/2026 03:58 PM Eastern
Extended Trading
$62.70 +0.77 (+1.24%)
As of 07:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

LeMaitre Vascular stock logo

LeMaitre Vascular NASDAQ:LMAT

$80.49 -1.23 (-1.51%)
Closing price 09/3/2026 04:00 PM Eastern
Extended Trading
$80.50 +0.01 (+0.01%)
As of 07:58 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature. The company also provides artegraft biologic graft, a bovine carotid artery used for dialysis access; XenoSure biologic patches, used for closure of vessels after surgical intervention; VascuCel and CardioCel biologic patches, used in vessel repair, heart repair and reconstruction, and neonatal repairs; cardiovascular patches; carotid shunts that temporarily shunt the blood to the brain during the removal of plaque in a carotid endarterectomy surgery; biosynthetic vascular graft indicated for lower extremity bypass and dialysis access; and vascular grafts used to bypass or replace diseased arteries. In addition, it offers radiopaque tape, a medical-grade tape applied to the skin that enables surgeons and interventionalists to cross-refer between the inside and the outside of a patient's body and allows them to locate tributaries or lesions beneath the skin. Further, the company provides valvulotomes, which cut or disrupt valves in the saphenous vein to function as an artery to carry blood past diseased arteries to the lower leg or the foot; and closure systems to attach vessels to one another with titanium clips instead of sutures. It markets its products through a direct sales force and distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts.

NeuroPace stock logo

NeuroPace NASDAQ:NPCE

$14.75 -0.44 (-2.90%)
As of 09/3/2026 04:00 PM Eastern

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Omnicell stock logo

Omnicell NASDAQ:OMCL

$34.82 +0.11 (+0.32%)
Closing price 09/3/2026 04:00 PM Eastern
Extended Trading
$34.60 -0.22 (-0.63%)
As of 07:57 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas